2 studies found for:    17634458 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Evaluation of Health Costs and Resource Utilization
Conditions: Ulcerative Colitis;   Crohn's Disease
Interventions: Other: Measurement of drug (Adalimumab/Infliximab);   Other: Intensify treatment with the existing drug
2 Completed A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)
Condition: Crohn's Disease
Intervention: Drug: Certolizumab Pegol (CDP870)

Indicates status has not been verified in more than two years